Skip to main content

Peer Review reports

From: New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis

Original Submission
14 Jan 2024 Submitted Original manuscript
13 Mar 2024 Reviewed Reviewer Report
10 May 2024 Reviewed Reviewer Report - Peng Wang
27 May 2024 Author responded Author comments - Yu-Chong Peng
Resubmission - Version 2
27 May 2024 Submitted Manuscript version 2
Publishing
30 May 2024 Editorially accepted
6 Jun 2024 Article published 10.1186/s12885-024-12453-w

You can find further information about peer review here.

Back to article page